Body Dysmorphic Disorder Clinical Trial
Official title:
Internet Delivered Cognitive Behavior Therapy for Body Dysmorphic Disorder - a Randomized Controlled Trial
Verified date | August 2017 |
Source | Karolinska Institutet |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To evaluate if Internet delivered cognitive behavior therapy is an efficacious treatment when compared to a control group consisting of supportive therapy.
Status | Completed |
Enrollment | 94 |
Est. completion date | January 2015 |
Est. primary completion date | January 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - outpatient - = 18 years - primary diagnosis of BDD according to the DSM-5 - BDD-YBOCS =20 - regular access to a computer with Internet access and skills to use the web. Exclusion Criteria: - psychotropic medication changes within two months prior to the treatment, - completed CBT for BDD within the last 12 months, - other primary axis I diagnosis - current substance dependence - lifetime bipolar disorder or psychosis - suicidal ideation - Axis II diagnosis that could jeopardize treatment participation, - other current psychological treatment that could affect BDD symptoms - A serious medical illness that precludes participation in the study |
Country | Name | City | State |
---|---|---|---|
Sweden | M46: Karolinska Universitetssjukhuset, Psykiatri Sydväst | Stockholm | Huddinge |
Lead Sponsor | Collaborator |
---|---|
Karolinska Institutet |
Sweden,
Enander J, Andersson E, Mataix-Cols D, Lichtenstein L, Alström K, Andersson G, Ljótsson B, Rück C. Therapist guided internet based cognitive behavioural therapy for body dysmorphic disorder: single blind randomised controlled trial. BMJ. 2016 Feb 2;352:i2 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Body Dysmorphic Disorder Modification of the Y-BOCS (BDD-YBOCS) | Change in BDD-YBOCS from baseline (week 0) to post-treatment (week 12) | ||
Secondary | The Montgomery Åsberg Depression Rating Scale - self report (MADRS-S) | Change in MADRS-S from baseline (week 0) to post-treatment (week 12) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02635152 -
Interpretation Bias Modification for Body Dysmorphic Disorder
|
N/A | |
Completed |
NCT03673046 -
Waitlist-Control Trial of Smartphone Cognitive Behavioral Therapy (CBT) for Body Dysmorphic Disorder (BDD)
|
N/A | |
Recruiting |
NCT05402475 -
Online Cognitive Behavioural Therapy Intervention for Body Dysmorphic Disorder
|
N/A | |
Withdrawn |
NCT02843451 -
Milk Thistle in Body Dysmorphic Disorder
|
Phase 2 | |
Completed |
NCT00842309 -
D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder
|
Early Phase 1 | |
Completed |
NCT00245635 -
Fluoxetine in Pediatric Body Dysmorphic Disorder
|
Phase 4 | |
Completed |
NCT02808702 -
Brain Correlates of Self-Focused Processing
|
N/A | |
Completed |
NCT01002326 -
Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic Disorder
|
N/A | |
Active, not recruiting |
NCT01075672 -
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals
|
N/A | |
Completed |
NCT02671266 -
Oxytocin Administration in BDD and OCD
|
Phase 2 | |
Completed |
NCT01038128 -
An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder
|
N/A | |
Completed |
NCT01398865 -
Escitalopram Neuroimaging Supplement
|
N/A | |
Completed |
NCT00265109 -
Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder
|
Phase 4 | |
Recruiting |
NCT04373629 -
Perceptual Abnormalities and Their Malleability in BDD
|
N/A | |
Completed |
NCT01453439 -
Cognitive-Behavioral Therapy and Supportive Psychotherapy for Body Dysmorphic Disorder
|
N/A | |
Completed |
NCT00871143 -
Cognitive Behaviour Therapy (CBT) for Body Dysmorphic Disorder (BDD)
|
N/A | |
Completed |
NCT00106223 -
Treatment Study Investigating New Cognitive Behavioral Therapy Treatment Manual for Body Dysmorphic Disorder
|
N/A | |
Active, not recruiting |
NCT00211809 -
CBT as an Adjunct to SRIs in the Treatment of BDD
|
Phase 4 |